title: IV injection dose less than 5 microgram
text: IV injection dose less than 5 microgram
  Draw up 20 microgram and make up to 1 mL total volume with 0.9% sodium chloride
  Concentration now equal to 2 microgram/0.1 mL
  Infuse over 15-30 minutes
  IV injection dose 5 microgram or more
  Use undiluted
  Infuse over 15-30 minutes
  In emergency situations, inject undiluted over 3 minutes
  SUBCUTANEOUS
  Dose less than 5 microgram
  Draw up 20 microgram and make up to 1 mL total volume with 0.9% sodium chloride
  Concentration now equal to 2 microgram/0.1 mL
  Dose 5 microgram or more
  Use undiluted
  Allow solution to reach room temperature before administration (minimises discomfort)
  Subcutaneous injection into the anterolateral thigh (use a subcutaneous delivery device for longer term administration)
  Rotate injection sites
  Stability :
  |
  Ampoules: until expiry date on label
  Infusion solution is stable for 24 hours at room temperature (25˚C) in sodium chloride 0.9%
  |
  Storage :
  |
  Ampoules: Refrigerate between 2-8 degree celsius. Protect from light.
  |
  Compatability:
  |
  5% Dextrose, 0.9% NaCl (preferred infusion fluid), Heparin, Potassium and TPN via a Y site.
  |
  Incompatibility :
  |
  Insulin, Pantoprazole
  |
  Serum Levels :
  |
  Not required
  |
  References
  1. British National Formulary for Children (BNFC) online. Octreotide. [Internet]: Royal Pharmaceutical Society; [cited 24-12-2020]. Available from: https://www.medicinescomplete.com.
  2. IBM Micromedex®Neofax®. Octreotide. In: IBM Micromedex® NeoFax®/Pediatrics (electronic version). [Internet]. IBM Watson Health, Greenwood Village, Colorado, USA. J [cited 24-12-2020]. Available from: http://neofax.micromedexsolutions.com/neofax.
  3. Australian Medicines Handbook Children's Dosing Companion. Octreotide. [Internet]. Adelaide: Australian Medicines Hanbook Pty Ltd; [cited 24-12-2020]. Available from: https://amhonline.amh.net.au.
  4. Ainsworth S. Neonatal Forumlary: Drug Use in Pregnancy and the First Year of Life. 7th ed. West Sussex: Wiley Blackwell; 2015.
  5. Australian Injectable Drugs Handbook. Nicolette Burridge, Keli Symons, editors. Octreotide. 7th ed. [Internet]. New South Wales: Society of Hospital Pharmacists of Australia (SHPA); [cited 24-12-2020]. Available from: https://aidh.hcn.com.au.
  6. Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database of Systematic Reviews. 2010; Issue 9. Art. No.: CD006388 DOI:10.1002/14651858.CD006388.pub2
  |